Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on October 27, 2005

Arteriosclerosis, Thrombosis, and Vascular Biology. 2005
Published online before print October 27, 2005, doi: 10.1161/01.ATV.0000193567.88685.f4
A more recent version of this article appeared on January 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/1/136    most recent
01.ATV.0000193567.88685.f4v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hemdahl, A.-L.
Right arrow Articles by Hansson, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hemdahl, A.-L.
Right arrow Articles by Hansson, G. K.

Submitted on December 9, 2004
Accepted on September 26, 2005

Expression of Neutrophil Gelatinase-Associated Lipocalin in Atherosclerosis and Myocardial Infarction

Anne-Louise Hemdahl ; Anders Gabrielsen ; Chaoyong Zhu ; Per Eriksson ; Ulf Hedin ; Jens Kastrup ; Peter Thorén ; and Göran K. Hansson *

From the Center for Molecular Medicine and Department of Medicine (A.-L.H., A.G., G.K.H.), Karolinska Hospital, Stockholm, Sweden; the Department of Physiology and Pharmacology (A.-L.H., P.T.) and King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital M1 (C.Z., P.E.), Karolinska Institute, Stockholm, Sweden; the Division for Vascular Surgery (U.H.), Department of Surgical Sciences, Karolinska University Hospital, Stockholm, Sweden; and the Cardiac Catheterization Laboratory 2014 (J.K.), The Heart Centre, Rigshospitalet, Copenhagen, Denmark.

* To whom correspondence should be addressed. E-mail: Goran.Hansson{at}cmm.ki.se.

Objective--Neutrophil gelatinase-associated lipocalin (NGAL) modulates the activity of matrix metalloproteinase (MMP) 9, an important mediator of vascular remodeling and plaque instability in atherosclerosis. This study aimed to analyze the expression of NGAL in atherosclerotic plaques and myocardial infarction (MI).

Methods and Results--Atherosclerotic apolipoprotein E (apoE)-/- x low-density lipoprotein receptor (LDLR)-/- and C57BL/6J control mice were exposed to brief hypoxic stress (10 minutes of 10% oxygen). Expression of the mouse NGAL homolog (24p3) and MMP-9 was analyzed 48 hours later by quantitative RT-PCR, immunohistochemistry, and zymography. Hypoxic stress increased NGAL/24p3 mRNA in the cardiac vasculature. NGAL/24p3 was also increased in atherosclerotic plaques of apolipoprotein E-/- x LDLR-/- mice compared with C57BL/6J mice. Mice developing MI exhibited the highest plaque mRNA expression of NGAL/24p3 and MMP-9. Zymography revealed strong proteolytic activity in areas rich in 24p3 and MMP-9 protein. Immunohistochemistry performed on human carotid endarterectomy specimens and control tissue from the internal mammary artery showed colocalization of MMP-9 and NGAL with macrophages in the atherosclerotic plaques.

Conclusions--NGAL/24p3 is increased in atherosclerotic plaques and MI. Colocalization with MMP-9 in areas with high-proteolytic activity suggests a role for NGAL/24p3 in modulating the MMP-9-mediated remodeling of plaques and infarcted hearts.


Key words: atherosclerosis • myocardial infarction • ischemia • hypoxia • matrix metalloproteinase • remodeling




This article has been cited by other articles:


Home page
Eur Heart JHome page
A. Yndestad, L. Landro, T. Ueland, C. P. Dahl, T. H. Flo, L. E. Vinge, T. Espevik, S. S. Froland, C. Husberg, G. Christensen, et al.
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
Eur. Heart J., May 2, 2009; 30(10): 1229 - 1236.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. R. Chan, J. S. Liu, D. A. Pociask, M. Zheng, T. A. Mietzner, T. Berger, T. W. Mak, M. C. Clifton, R. K. Strong, P. Ray, et al.
Lipocalin 2 Is Required for Pulmonary Host Defense against Klebsiella Infection
J. Immunol., April 15, 2009; 182(8): 4947 - 4956.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E. Diamanti-Kandarakis, S. Livadas, S. A Kandarakis, A. Margeli, and I. Papassotiriou
Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
Eur. J. Endocrinol., April 1, 2008; 158(4): 525 - 531.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
K M Choi, J S Lee, E J Kim, S H Baik, H S Seo, D S Choi, D J Oh, and C G Park
Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease
Eur. J. Endocrinol., February 1, 2008; 158(2): 203 - 207.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Zernecke, I. Bot, Y. Djalali-Talab, E. Shagdarsuren, K. Bidzhekov, S. Meiler, R. Krohn, A. Schober, M. Sperandio, O. Soehnlein, et al.
Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis
Circ. Res., February 1, 2008; 102(2): 209 - 217.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Frank, C. Kuhn, B. Brors, C. Hanselmann, M. Ludde, H. A. Katus, and N. Frey
Gene Expression Pattern in Biomechanically Stretched Cardiomyocytes: Evidence for a Stretch-Specific Gene Program
Hypertension, February 1, 2008; 51(2): 309 - 318.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H. Bachorzewska-Gajewska, J. Malyszko, E. Sitniewska, J. S. Malyszko, and S. Dobrzycki
Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 295 - 296.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D.-x. Bu, A.-L. Hemdahl, A. Gabrielsen, J. Fuxe, C. Zhu, P. Eriksson, and Z.-q. Yan
Induction of Neutrophil Gelatinase-Associated Lipocalin in Vascular Injury via Activation of Nuclear Factor-{kappa}B
Am. J. Pathol., December 1, 2006; 169(6): 2245 - 2253.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Garg, M. Rojas, A. Ravi, K. Bockbrader, S. Epstein, M. Vijay-Kumar, A. T. Gewirtz, D. Merlin, and S. V. Sitaraman
Selective Ablation of Matrix Metalloproteinase-2 Exacerbates Experimental Colitis: Contrasting Role of Gelatinases in the Pathogenesis of Colitis
J. Immunol., September 15, 2006; 177(6): 4103 - 4112.
[Abstract] [Full Text] [PDF]